 |
|
Combining Tricyclic and Monoamine Oxidase Inhibitor Antidepressants
Duane G. Spiker, MD;
Daniel D. Pugh, MD
Arch Gen Psychiatry. 1976;33(7):828-830.
Abstract
• The charts of 150 inpatients and 51 outpatients treated with a monoamine oxidase inhibitor (MAOI)-tricyclic antidepressant combination were reviewed. The incidence and severity of side effects among the patients on the combined regimen were essentially the same as those seen in the control groups. There were no deaths or strokes resulting from use of this regimen. The most frequent troublesome side effect was orthostatic hypotension.
We conclude that the use of a MAOI-tricyclic combination in oral therapeutic doses is safe. However, the efficacy of this combination has not yet been proved, and it may be particularly toxic if taken in an overdose.
Author Affiliations
From the Department of Psychiatry, Washington University School of Medicine (Drs Spiker and Pugh); and the Malcolm Bliss Mental Health Center, St Louis (Dr Pugh). Dr Spiker is now with the University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic, Pittsburgh.
Footnotes
Accepted for publication Dec 15, 1975.
Reprint requests to Department of Psychiatry, University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic, 3811 O'Hara St, Pittsburgh, PA 15261 (Dr Spiker).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Lithium Carbonate Addition in Tricyclic Antidepressant--Resistant Unipolar Depression: Correlations With the Neurobiologic Actions of Tricyclic Antidepressant Drugs and Lithium Ion on the Serotonin System
de Montigny et al.
Arch Gen Psychiatry 1983;40:1327-1334.
ABSTRACT
|
